JP Morgan Maintains Overweight on Signature Bank, Lowers Price Target to $300

JP Morgan analyst Steven Alexopoulos maintains Signature Bank (NASDAQ:SBNY) with a Overweight and lowers the price target from $460 to $300.

JP Morgan analyst Steven Alexopoulos maintains Signature Bank (NASDAQ:SBNY) with a Overweight and lowers the price target from $460 to $300.

Total
0
Shares
Related Posts
Read More

RenovoRx, Inc. Announces $5M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules With A Certain Institutional Investor For The Purchase And Sale Of 1,557,632 Shares Of Common Stock At A Price Of $3.21/Share; Shares Halted On Circuit Brea…

RenovoRx, Inc. (the "Company") (NASDAQ:RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, today announced that it has entered into a definitive securities purchase agreement

RNXT